Stay updated on Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page.

Latest updates to the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the study's purpose, inclusion and exclusion criteria, and details about the clinical trial. The only notable addition is the mention of 'PD1 plus DC-CIK' and a revision update.SummaryDifference31%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page.